Category Archives: drugs

Omics technologies

According to the Deputy Head of the Research Institute of Clinical and Experimental Lymphology for scientific work, Doctor of Medical Sciences Vadim Klimontov: “Omixes” are technologies which are based on the achievements of genomics, transcriptomics, proteomics, metabolomics, that means, sciences that study how the genome is arranged and how the information, which is encoded in it, implemented. How it is

Read more

Orphan diseases

According to the All-Russian Society of Orphan Diseases, about 30 million patients with rare diseases were registered in the European Union. This means that every 15th European suffers from one or another orphan disease. The figures are impressive, given that the synonym for orphan diseases is “rare diseases”. Federal Law 323 states that orphan disease is a disease the prevalence

Read more

Botulinum toxin – poison or drug?

Not so long ago it became known that the American biopharmaceutical company AbbVie became the lucky owner of the Irish manufacturer of drugs Allergan. According to the representative of AbbVie, this acquisition will allow the company to focus on the development of new drugs without compromising the business. Allergan’s portfolio includes drugs for the treatment of ophthalmic, neurological and gastrointestinal

Read more

Reference, generic and biosimilar drugs

As part of the consideration of the procedure for registration of medicines it is worth paying attention to such groups of drugs as reference (= Brand name), generic and biosimilar drugs. According to statistics, more than 60% of drugs on the Russian market are generics, or reproduced drugs. Definitions According to the Federal Law 61 reference drug is called a

Read more

Approvals for drugs

Our new topic about drugs regulation: what are drugs and how to determine it from borderline products? how to receive state registration and permission for clinical trials? what actions are required for pharmaceutical substance? Find answers in our new big topic – by link.

Read more